Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy.
about
Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analogue treatment.Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatmentReview article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.Viral Biomarkers in Chronic HBeAg Negative HBV Infection
P2860
Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Relationship between HBsAg, HB ...... A under nucleos(t)ide therapy.
@en
type
label
Relationship between HBsAg, HB ...... A under nucleos(t)ide therapy.
@en
prefLabel
Relationship between HBsAg, HB ...... A under nucleos(t)ide therapy.
@en
P2860
P50
P356
P1476
Relationship between HBsAg, HB ...... A under nucleos(t)ide therapy.
@en
P2093
D K-H Wong
P2860
P304
P356
10.1111/JVH.12688
P577
2017-02-10T00:00:00Z